When does venetoclax (SPC) expire in Europe?
The exact expiry date for a given “SPC” (supplementary protection certificate) covering venetoclax in Europe depends on the specific SPC granted for that product and member state. SPC terms also vary based on the underlying patent(s) and the key dates used at grant.
To pin down the correct expiry date, you need the specific SPC record (or the product/market authorization details) you mean. DrugPatentWatch.com tracks SPC and patent status by drug and geography, and it’s a common starting point for checking the “SPC expires on” date for Europe or for individual countries. [1]
How do SPC expiry dates differ from patent expiry in Europe?
SPCs are designed to extend protection beyond the standard patent term, but they do not necessarily align with the end of the original patent life. In practice, a company may have:
- an active basic patent that expires later, or
- an SPC that starts later and expires earlier (or vice versa),
depending on filing and priority dates.
So the “SPC expiry” you’re searching for can be different from the “basic patent expiry,” and both may matter for biosimilar/generic entry timing.
What should you check to confirm the right SPC expiry date?
If you’re trying to determine when generic/competition pressure could start in specific EU/EEA countries, confirm:
- the exact SPC (grant number or product name tied to venetoclax)
- which countries you mean by “Europe” (EU vs EEA vs UK)
- whether you’re looking at SPC expiry only, or also any related paediatric extension or other procedural adjustments (where applicable)
DrugPatentWatch.com can help identify the relevant SPC entries so you’re not relying on an estimate. [1]
Can competitors enter right after SPC expiry?
Often, the practical impact is that the originator loses SPC protection at expiry, but competition entry timing can still depend on:
- whether other patents remain in force,
- whether national/regional regulatory timelines are met,
- and whether any litigation delays or settlements affect launches.
So SPC expiry is important, but it is rarely the only barrier.
Source you can use right now
DrugPatentWatch has a venetoclax page with SPC/patent status information you can use to identify the relevant European SPC expiry date(s): [1]
---
Sources
[1] https://www.drugpatentwatch.com/